Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III trial of Human Fibrinogen

Trial Profile

A Phase III trial of Human Fibrinogen

Phase of Trial: Phase III

Latest Information Update: 12 Oct 2017

At a glance

  • Drugs Fibrinogen (Primary)
  • Indications Afibrinogenaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Oct 2017 New trial record
    • 09 Oct 2017 According to a China Biologic Products media release, the company has received approval to begin Phase III clinical trials for Fibrinogen in 2012.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top